NEW YORK (GenomeWeb News) – Rubicon Genomics said this week that its 2013 revenues increased 85 percent year over year on sales of its nucleic acid library preparation products, ThruPlex-FD Prep Kits and PicoPlex WGA Kits. ThruPlex-FD Prep Kits for Illumina’s next-generation sequencing platforms provides sequencing from challenging samples with very small amounts of DNA or degraded DNA, Rubicon said. PicoPlex-WGA Kits amplify DNA to yield a highly reproducible library from single cells with input concentrations as low as 15 picograms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.